NY Times

Vaccines for young children are being delayed by incomplete data, a top F.D.A. official suggests.

Moderna and the Pfizer-BioNTech partnership are developing versions of their coronavirus vaccines for children under 5, with emergency-use filings expected soon.

Continue

About the author

Darlene

Leave a Comment